LDL-C

Results: TFBL remarkably reduced LDL C and serum glucose, raised HDL C, improved lipid metabolic disorder and glucose tolerance.

结果：TFBL能明显降低高脂血症和糖尿病大鼠的血清LDLC，升高HDLC，降低血糖，改善糖耐量。

Methods: TC, TG, HDL C, LDL C, blood glucose ( BG ) and EKG were determined in 906 elderly persons.

方法　采用 标准化 方法测定血清总胆固醇(TC) 、 甘油三脂(TG) 、 高密度蛋白胆固醇(HDLC) 、 低密度脂蛋白胆固醇(LDLC) 、 血糖 ( BG ) 水平,与常规12导联心电图比较分析.

Results The TC, TG, LDL-C and FBC were decreased and HDL-C increased after therapy.

结果　治疗后血TC 、 TG 、 LDL -C 、FBC水平明显下降,HDL -C 水平升高.

Of the patients that had low LDL-C concentrations, normal triglyceride and HDL-C levels, 14 percent had an elevated LDL particle number.

参与研究的病人有低低密度脂蛋白胆固醇水平，正常的甘油三酯和高密度脂蛋白胆固醇水平，有14%的患者低密度脂蛋白粒子数升高。

The common consensus is that lowering low-density lipoprotein cholesterol (LDL-C) levels prevents atherosclerotic cardiovascular disease.

一般而言，降低低密度脂蛋白胆固醇（LDL-C）水平可预防动脉粥样硬化性心血管疾病。

NCEP guidelines which classify CVD risk on the basis of LDL-C level, are helpful in targeting individuals at risk early in life.

成人准则分类心血管疾病危险的基础上，LDL-C水平，有利于针对个人在早期生活中的风险。

For patients whose LDL C reductions were above the median value.

低密度脂蛋白胆固醇降低高于中间值的病人.

Conclusions: Very low LDL-C and normal SBP are associated with the slowest progression of coronary atherosclerosis.

结论: 非常低水平的LDL -C 和正常SBP与较慢的冠状动脉粥样硬化进展相关.

Multivariate analysis revealed that the drop in LDL-C and increase in HDL-C both independently predicted atheroma regression.

多变量分析显示LDL-C水平的降低以及HDL-C水平的增加各自都能改善动脉粥样硬化。

However, stating, despite producing marked reductions in LDL-C, are not associated with an increased risk of cancer.

然而，仅管他汀类药物能显著减低低密度脂蛋白，但它与癌症发生率的增高并无内在联系。

Blood LDL-c, apoB increased significantly after peritonitis.

CAPD组 在发生腹膜炎后血ldl-c、 、 apoB较 未发生之前显著增高.

The common consensus is that lowering low-density lipoprotein cholesterol ( LDL-C ) levels prevents atherosclerotic cardiovascular disease.

一般而言,降低 低密度 脂蛋白胆固醇 ( LDL -C ) 水平可预防动脉粥样硬化性心血管疾病.

Conclusions: There is an inverse association between on-treatment LDL-C and incident cancer.

结论：经他汀类药物处理的低密度脂蛋白水平与癌症发生存在负相关。

LDL-C , age, sex and smoking may be the risk factors of subclinical AS in LADA patients.

LDL -C 、吸烟 、 性别 、 年龄及HOMA-IR 可能是LADA患者IMT增加 的主要影响因素.

These inflammatory parameters did not further reduced, but hs-CRP reduced further at the end of 8-week therapy.

治疗8周末LDL -C 、TC未 见进一步下降, 但hs-CRP仍有进一步降低.

Probucol did not change serum levl of TG, but the serum levels of TC and LDL-C were significantly lowered.

普罗布考对甘油三酯无明显影响，但是血清总胆固醇及低密度脂蛋白胆固醇均明显降低。

Effects on LDL-C and AI, as well as on gene expression of TSG were first reported.

其中,TSG对于LDL -C 和AI的调节作用, 以及对基因表达的影响为首次报道.

There was a postive correlation between plasma FFA and hsCRP.

血浆FFA与 hsCRP水平呈正相关;(3)血浆FFA、hsCRP、 TG、 LDL-c 水平与大血管病变呈正相关.

Elevated serum low-density lipoprotein-cholesterol(LDL-C)is a major risk factor for cardiovascular diseases.

血清低密度脂蛋白-胆固醇（LDL-C）升高是心血管疾病的一个重要危险因素。

No significant changes in total cholesterol. LDL-C, triglycerides, and vitamin E levels were observed.

观察中总胆固醇，低密度脂蛋白和维生素E的水平没有明显的改变。

Apo E ε4 can increase plasma total cholestero ( TC ) and low-density lipoprotein cholesterol ( LDL-C ) lev-els , while Apo E ε2 decrease them.

Apo 　Eε4等位基因具有升高TC、LDL - C的作用, Apo　Eε2等位基因则有降低TC、LDL- C的作用.

Danshen yin could decrease the level of TC and LDL-c in serum ( P & lt; 0.05 ).

丹参饮亦能降低血清TC、LDL-c的含量 ( P & lt; 0.05 ).